Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 28, 2005

View Archived Issues

Targeting NPY-2 for genetic generalized epilepsies

Linolenic acid supplementation and ketogenic diet elicit comparable anticonvulsant effects in rats

Novel agents for treating neurological disorders disclosed in recent patent literature

Acetyl-CoA carboxylase inhibitors emerge from Ajinomoto R&D

Recent patents cover novel compounds with potential for treatment of cancer

Erbitux receives Swiss approval for head and neck cancer

Quest PharmaTech advances development of ACP-SL017

Neose Technologies updates NE-180 program

ANA-975 to begin phase Ib study in chronic hepatitis C patients

Introgen updates Advexin regulatory status

EntreMed to acquire Miikana Therapeutics

Fornix changes corporate structure and updates research programs

Ranbaxy and Cephalon settle Provigil patent infringement dispute in U.S.

Pennsaid confirmed effective in osteoarthritis of the knee

Bavarian Nordic updates program progress

Orencia approved for rheumatoid arthritis

Approvable letter for Daytrana

Astellas submits NDA for FK-506 modified release formulation

Plk1 inhibitors as tools to study cell division processes

Aricept orodispersible tablet completes Europe mutual recognition procedure

Adalimumab submitted for approval in Japan

New data on antibacterial activity of DX-619

Calcitonin effective, reduces biomarkers of joint metabolism in knee osteoarthritis

Oblimersen evaluated in myeloid and lymphocytic leukemia

Febuxostat may be superior to allopurinol in treating hyperuricemia and gout

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...